Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Pliant Therapeutics
PLRX
$65M
| $4.24M | ﹤0.01% |
244,266
+152,190
| +165% | +$2.64M |
|
1402
Teck Resources
TECK
$32.6B
| $4.23M | ﹤0.01% |
98,244
+35,864
| +57% | +$1.49M |
|
|
SF
1403
Stifel
SF
$12.6B
| $4.23M | ﹤0.01% |
103,257
-21,828
| -17% | -$919K |
|
1404
BellRing Brands
BRBR
$1.34B
| $4.23M | ﹤0.01% |
102,554
-69,410
| -40% | -$2.66M |
|
1405
KBR
KBR
$4.8B
| $4.22M | ﹤0.01% |
71,584
-35,129
| -33% | -$2.16M |
|
1406
Southern Copper
SCCO
$166B
| $4.21M | ﹤0.01% |
60,368
+25,584
| +74% | +$1.87M |
|
|
VRNT
1407
DELISTED
Verint Systems
VRNT
| $4.2M | ﹤0.01% |
182,604
-186,853
| -51% | -$6.02M |
|
1408
ACI Worldwide
ACIW
$5.42B
| $4.2M | ﹤0.01% |
186,052
-15,120
| -8% | -$353K |
|
1409
Mattel
MAT
$4.23B
| $4.19M | ﹤0.01% |
190,378
-31,014
| -14% | -$662K |
|
1410
Insperity
NSP
$2.01B
| $4.19M | ﹤0.01% |
42,915
-26,907
| -39% | -$2.81M |
|
1411
iQIYI
IQ
$1.28B
| $4.19M | ﹤0.01% |
883,598
+604,681
| +217% | +$3.15M |
|
1412
Sprott Uranium Miners ETF
URNM
$1.98B
| $4.17M | ﹤0.01% |
+88,506
| New | +$3.33M |
|
1413
Upstart Holdings
UPST
$3.03B
| $4.17M | ﹤0.01% |
146,159
+41,261
| +39% | +$1.66M |
|
1414
Martin Midstream Partners
MMLP
$95.9M
| $4.17M | ﹤0.01% |
1,500,000
| – | – |
|
1415
Marriott Vacations Worldwide
VAC
$4.25B
| $4.17M | ﹤0.01% |
41,424
-67,026
| -62% | -$7.64M |
|
1416
ATI
ATI
$31B
| $4.16M | ﹤0.01% |
101,048
+22,446
| +29% | +$998K |
|
1417
Prothena Corp
PRTA
$450M
| $4.15M | ﹤0.01% |
86,035
+18,223
| +27% | +$1.08M |
|
1418
Power Integrations
POWI
$3.61B
| $4.13M | ﹤0.01% |
54,163
-6,192
| -10% | -$530K |
|
|
BERY
1419
DELISTED
Berry Global Group, Inc.
BERY
| $4.13M | ﹤0.01% |
72,690
-8,267
| -10% | -$486K |
|
1420
Doximity
DOCS
$4.88B
| $4.13M | ﹤0.01% |
194,682
-9,299
| -5% | -$254K |
|
|
DVAX
1421
DELISTED
Dynavax Technologies
DVAX
| $4.11M | ﹤0.01% |
278,166
+24,156
| +10% | +$340K |
|
1422
Bloomin' Brands
BLMN
$938M
| $4.11M | ﹤0.01% |
167,046
-85,376
| -34% | -$2.27M |
|
|
ORAN
1423
DELISTED
Orange
ORAN
| $4.1M | ﹤0.01% |
357,145
+50,325
| +16% | +$575K |
|
1424
CALL
Elevance Health
ELV
$85.5B
| $4.09M | ﹤0.01% |
+9,400
| New | +$4.26M |
|
|
1425
PUT
Elevance Health
ELV
$85.5B
| $4.09M | ﹤0.01% |
+9,400
| New | +$4.26M |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.